Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Estrogen and Cognitive Functioning in Women with Bilateral Salpingo-Oophorectomy
FY 2016-17
Summary
In women who carry a mutation of the Breast Cancer 1 and 2 genes (BRCA 1/2), a bilateral salpingo-oophorectomy (BSO) is often recommended as a preventative measure against breast and ovarian cancer. However, this removal of the ovaries abruptly induces an estrogen-deprived state known as surgical menopause. Previous research has shown that estrogen deprivation has a negative impact on cognition, and in later years, this population of women who undergo BSO show higher incidence of dementia, including Alzheimer's disease. In this study, performance on a cognitive battery will be evaluated over time in a group of women with BSO, as compared to women with the BRCA 1/2 mutation who have not yet received BSO, and an age-matched control group. Furthermore, the impact of estrogen levels during testing, the age when BSO was received, and the interaction of the APOE gene will also be evaluated. Past research shows that younger women who undergo BSO are more subject to cognitive deficits, as they enter surgical menopause earlier than they would naturally. Additionally, the APOE gene has been identified as a significant risk factor for dementia, and it is thought that carriers of this gene who undergo BSO would be at an increased risk. Therefore, it is hypothesized that women who have received BSO will show a decline in cognition over time as compared to the BRCA 1/2 and age-matched control groups, and that this decline will be increased in women who received BSO at a younger age, and/or who are carriers of the APOE gene. Overall, the implications of this research will serve to give women with the BRCA 1/2 mutation a more informed choice about BSO, as well as provide a greater understanding of the function of the ovaries and endogenous estrogen in women's overall health.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
367317
Name
Reuben Rebekah B
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Estrogen and Cognitive Functioning in Women with Bilateral Salpingo-Oophorectomy
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Brca Mutation; Cognitive Decline; Cognitive Neuroscience; Estrogen; Oophorectomy; Surgical Menopause; Women'S Health
Abstract
In women who carry a mutation of the Breast Cancer 1 and 2 genes (BRCA 1/2), a bilateral salpingo-oophorectomy (BSO) is often recommended as a preventative measure against breast and ovarian cancer. However, this removal of the ovaries abruptly induces an estrogen-deprived state known as surgical menopause. Previous research has shown that estrogen deprivation has a negative impact on cognition, and in later years, this population of women who undergo BSO show higher incidence of dementia, including Alzheimer's disease. In this study, performance on a cognitive battery will be evaluated over time in a group of women with BSO, as compared to women with the BRCA 1/2 mutation who have not yet received BSO, and an age-matched control group. Furthermore, the impact of estrogen levels during testing, the age when BSO was received, and the interaction of the APOE gene will also be evaluated. Past research shows that younger women who undergo BSO are more subject to cognitive deficits, as they enter surgical menopause earlier than they would naturally. Additionally, the APOE gene has been identified as a significant risk factor for dementia, and it is thought that carriers of this gene who undergo BSO would be at an increased risk. Therefore, it is hypothesized that women who have received BSO will show a decline in cognition over time as compared to the BRCA 1/2 and age-matched control groups, and that this decline will be increased in women who received BSO at a younger age, and/or who are carriers of the APOE gene. Overall, the implications of this research will serve to give women with the BRCA 1/2 mutation a more informed choice about BSO, as well as provide a greater understanding of the function of the ovaries and endogenous estrogen in women's overall health.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Reuben, Rebekah B
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~